BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36895015)

  • 1. CRS: a circadian rhythm score model for predicting prognosis and treatment response in cancer patients.
    Liu Y; Guo S; Sun Y; Zhang C; Gan J; Ning S; Wang J
    J Transl Med; 2023 Mar; 21(1):185. PubMed ID: 36895015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omics and single-cell sequencing analyses reveal the potential significance of circadian pathways in cancer therapy.
    Lai H; Xiang X; Long X; Chen Z; Liu Y; Huang X
    Expert Rev Mol Diagn; 2024; 24(1-2):107-121. PubMed ID: 38288973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
    He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
    Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation.
    Wang Z; Su G; Dai Z; Meng M; Zhang H; Fan F; Liu Z; Zhang L; Weygant N; He F; Fang N; Zhang L; Cheng Q
    Cell Prolif; 2021 Mar; 54(3):e12988. PubMed ID: 33442944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis.
    Xian H; Li Y; Zou B; Chen Y; Yin H; Li X; Pan Y
    BMC Cancer; 2022 Jan; 22(1):107. PubMed ID: 35078435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Circadian Clock Signature for Tumor Microenvironment in Predicting Survival for Cutaneous Melanoma.
    Zeng N; Xia Q; Li Y; Ma L; Cheng Y; Chen Y; Lu Q; Lu Z; Wu D; Luo D
    Curr Pharm Des; 2022; 28(28):2349-2361. PubMed ID: 35927923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Novel Circadian Rhythm-Related Signature to Predict the Prognosis of the Patients with Hepatocellular Carcinoma.
    Wu Y; Shen C; Wang X; Zhao W; Li Y; He X; Chen Y; Liu J; Wu X; Shen A
    Biomed Res Int; 2022; 2022():4263261. PubMed ID: 35993051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights Into the Tumor Immune Microenvironment in Prostate Cancer.
    Feng D; Xiong Q; Zhang F; Shi X; Xu H; Wei W; Ai J; Yang L
    Front Immunol; 2022; 13():777724. PubMed ID: 35154101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research on circadian clock genes in common abdominal malignant tumors.
    Qiu MJ; Liu LP; Jin S; Fang XF; He XX; Xiong ZF; Yang SL
    Chronobiol Int; 2019 Jul; 36(7):906-918. PubMed ID: 31014126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation, functional implications, and prognostic ability of the circadian clock across cancers.
    Liu Z; Yu K; Zheng J; Lin H; Zhao Q; Zhang X; Feng W; Wang L; Xu J; Xie D; Zuo ZX; Liu ZX; Zheng Q
    Cancer Med; 2019 Apr; 8(4):1710-1720. PubMed ID: 30791227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression pattern and prognostic value of circadian clock genes in pancreatic adenocarcinoma.
    Zhang LL; He QK; Lv YN; Zhang ZJ; Xiang YK
    Chronobiol Int; 2021 May; 38(5):681-693. PubMed ID: 33691542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research on circadian clock genes in non-small-cell lung carcinoma.
    Qiu M; Chen YB; Jin S; Fang XF; He XX; Xiong ZF; Yang SL
    Chronobiol Int; 2019 Jun; 36(6):739-750. PubMed ID: 31014124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired leukocyte trafficking and skin inflammatory responses in hamsters lacking a functional circadian system.
    Prendergast BJ; Cable EJ; Patel PN; Pyter LM; Onishi KG; Stevenson TJ; Ruby NF; Bradley SP
    Brain Behav Immun; 2013 Aug; 32():94-104. PubMed ID: 23474187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronopharmacological strategies focused on chrono-drug discovery.
    Ohdo S; Koyanagi S; Matsunaga N
    Pharmacol Ther; 2019 Oct; 202():72-90. PubMed ID: 31173839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma.
    Huang Z; He A; Wang J; Lu H; Zhang R; Wu L; Feng Q
    Aging (Albany NY); 2021 Jun; 13(12):16637-16655. PubMed ID: 34162762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research on the circadian clock gene HNF4a in different malignant tumors.
    Qiu MJ; Zhang L; Fang XF; Li QT; Zhu LS; Zhang B; Yang SL; Xiong ZF
    Int J Med Sci; 2021; 18(6):1339-1347. PubMed ID: 33628089
    [No Abstract]   [Full Text] [Related]  

  • 19. Epigenetic Basis of Circadian Rhythm Disruption in Cancer.
    Reszka E; Zienolddiny S
    Methods Mol Biol; 2018; 1856():173-201. PubMed ID: 30178252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated multi-omics analysis reveals the molecular interplay between circadian clocks and cancer pathogenesis.
    Pérez-Villa A; Echeverría-Garcés G; Ramos-Medina MJ; Prathap L; Martínez-López M; Ramírez-Sánchez D; García-Cárdenas JM; Armendáriz-Castillo I; Guerrero S; Paz C; López-Cortés A
    Sci Rep; 2023 Aug; 13(1):14198. PubMed ID: 37648722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.